Corcept Therapeutics Names Justin Gunn President of Endocrinology Division as Sean Maduck Retires Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on developing and commercializing medicines that modulate…
Cellares and Seoul National University Hospital Partner to Automate Manufacturing of Gene-Modified HSPC Therapy for PNH Cellares, an Integrated Development and Manufacturing Organization (IDMO), and Seoul National University Hospital (SNUH),…
NeuPath Health to Host 2026 Physician Forum Focused on Advances in Chronic and Musculoskeletal Pain Care NeuPath Health Inc. (TSXV: NPTH), a Canadian healthcare company operating one of the country’s…
Aurion Biotech Completes Enrollment in U.S. Phase 3 ASTRA Study of Regenerative Cell Therapy AURN001 Aurion Biotech, Inc., a commercial-stage regenerative cell therapy company focused on restoring vision, has announced…
ImmunoScape Appoints Peter Olagunju as CEO to Advance TCR-Based Cancer Immunotherapy Platform Toward the Clinic ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI, has appointed Peter…
StandardX Raises £10 Million to Build Scalable Isotope Refinery for Medicine and Fusion Energy StandardX, a UK-headquartered European deep technology company founded in 2025, has raised £10 million in seed…
Autobahn Therapeutics Reports Positive Phase 2 AMPLIFY-BD Results for Elunetirom in Bipolar Depression Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people living with neuropsychiatric disorders, announced the…
GreenMan Vision Study Finds Virtual Reality May Improve Cataract IOL Education and Patient Satisfaction GreenMan Vision, Inc. has announced the publication of a peer-reviewed, multi-center study evaluating InSightVR, a patient-specific…
Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel Pattern Bioscience, a company developing rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug…
Establishment Labs Presents New Breast Tissue Preservation Data and Expands Minimally Invasive Platform at WSEI Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company focused on advancing women’s…
Therapy Gains Ground as a Go-To Solution for Everyday Stress and Social Connection Modern Health, a global workplace mental health platform, has released new international research examining how employees use…
Alkermes Reports Positive Phase 1 Results for Investigational Orexin 2 Receptor Agonist ALKS 7290 in Adult ADHD Alkermes plc (Nasdaq: ALKS) has announced positive topline results from a Phase 1…